Changes in Self-Care Behavior (Summary of Diabetes Self-Care Activities Measure) Using Real-Time Blood Glucose Monitoring with the Free Style Libre

• DOI: 10.2337/db18-902-p
• Publication Date: 2018-06-22T18:57:35Z
• Authors: AYAE KUDARA; TAKAHIRO TOSAKI; SHIORI SATO; AKEMI INAGAKI; MASAKI KONDO; SHIN TSUNEKAWA; YOSHIRO KATO; HIDEKI KAMIYA; JIRO NAKAMURA
• Keywords: Glycated hemoglobin; Blood glucose monitoring; Blood Glucose Self-Monitoring

No studies have reported changes in self-care behavior, and it remains unclear whether Free Style Libre (Libre) differs from conventional blood glucose self-monitoring devices this regard. Therefore, we instructed diabetes patients using (SMBG) to use the prospectively examined effect of new device on behavior patient treatment satisfaction. The subjects comprised 41 outpatients with who were SMBG devices. randomly assigned group A, which for ≥2 weeks (n = 21), or B, continued 20). All received 30 minutes diet exercise therapy instruction a registered dietitian nurse (or clinical laboratory technologists). Summary Diabetes Self-Care Activities measure (SDSCA) was administered at baseline, 1, 3, 6 months. Changes SDSCA, glycated hemoglobin (HbA1c), albumin (GA), body weight baseline 1 month analyzed (UMIN000029016). At two groups did not differ significantly terms HbA1c, GA, weight, 17 SDSCA items. month, numbers days involving eating five more servings fruits vegetables 5.0 (3.3, 6.8) A 3.0 (1.0, 6.0) least (2.0, 2.0 (0, 3.0) number specific 1.5 2.3) B; both these values higher than B (p 0.033, 0.037 0.041, respectively). These results suggest that may improve behaviors regarding exercise, compared Disclosure A. Kudara: None. T. Tosaki: Other Relationship; Self; Eli Lilly Company, Takeda Development Center Asia, Pte. Ltd., MSD K.K., Mitsubishi Tanabe Pharma Corporation. S. Sato: Inagaki: M. Kondo: Tsunekawa: Y. Kato: Speaker's Bureau; Merck Sharp & Dohme Corp., Sanofi, Pharmaceutical Japan. H. Kamiya: Ono Co., Sanofi AstraZeneca, Astellas KK, Novartis Dainippon Sumitomo Ltd, Boehringer Ingelheim Pharmaceuticals, Inc., Ltd. J. Nakamura: US, Kyowa Hakko Kirin Kowa Pharmaceuticals America, Taisho Corporation, Pfizer Inc..